Yulia Slavina

Pacific Biosciences of California CEO explores future of long-read sequencing for newborn screening

Pacific Biosciences of California CEO explores future of long-read sequencing for newborn screening
PacBio CEO on sequencing future

Pacific Biosciences of California CEO Mark Van Oene appeared on Mendelspod this week to discuss the transformative potential of long-read sequencing in newborn screening.

Van Oene examined how genomic information collected at birth could shape healthcare outcomes and highlighted the evolving role of advanced sequencing technologies. The conversation provided insights into how long-read sequencing may unlock new diagnostic capabilities, offering a glimpse of the next frontier in precision medicine.

Earlier this year, Pacific Biosciences of California launched its HiFi WGS workflow, a rapid genomic sequencing solution that provides genome-wide variant calls in under 30 hours (link). The company has also contributed to advances in complete genome assemblies, with a Cell special issue highlighting 13 new assemblies enabled by its technology (link). These developments mark ongoing efforts to expand high-resolution genomic tools for researchers and clinicians.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.